KalVista Pharmaceuticals (KALV) Competitor Comparison
We are evaluating the key criteria listed to compare KalVista Pharmaceuticals (KALV) against its competitors in the Biotechnology industry.
Market Capitalization
160 / 368Gross Profits
225 / 278Total Revenue
0 / 300EBITDA
201 / 337Free Cashflow
191 / 352Quick Ratio
131 / 357Earnings per Share
272 / 359Dividend yield
0 / 6Total Cash
211 / 358Performance 3 years
139 / 368Performance 5 years
131 / 368Performance 10 years
239 / 368Linearity 3 years
65 / 368Linearity 5 years
3 / 368Linearity 10 years
252 / 368Total Rank
327 / 368Dividend Rank
177 / 368Valuation Rank
254 / 368Piotroski Rank
339 / 368Muliplier Rank
131 / 368Valuation Rank - KALV ranking 254 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.